NCT01730547View on ClinicalTrials.gov

Mesenchymal Stem Cells for Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 9, 2019

Study Completion Date

November 20, 2021

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Autologous mesenchymal stem cells

Trial Locations (1)

171 76

Karolinska Institute, Karolinska University Hospital Solna, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT01730547 - Mesenchymal Stem Cells for Multiple Sclerosis | Biotech Hunter | Biotech Hunter